Ares Capital Corporation's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Net-Income-Including-Non-Controlling-Interests" stands at 0.969 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the lowest value since 09/30/2023.
Ares Capital Corporation's second quarter result of 0.171 Billion USD for the item "Net Income Including Non Controlling Interests" represents an increase of 85.87 percent compared to it's first quarter result.
Also, Ares Capital Corporation's second quarter result of 0.171 Billion USD for the item "Net Income Including Non Controlling Interests" represents a decrease of -52.63 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Ares Capital Corporation's second quarter result of 0.969 Billion USD for the item "Net Income Including Non Controlling Interests" represents a decrease of -16.39 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.384 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.384 Billion United States Dollars.
The 3 year change is 0.082 Billion United States Dollars.
The 5 year change is -0.701 Billion United States Dollars.
The 10 year change is 0.5484 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Berkshire Hathaway Inc - Net Income Including Non Controlling Interests | 1,088,030,244,864.00 |
![]() | Blackstone Group Inc - Net Income Including Non Controlling Interests | 186,696,990,720.00 |
![]() | BlackRock Inc - Net Income Including Non Controlling Interests | 166,346,604,544.00 |
![]() | KKR & Co LP - Net Income Including Non Controlling Interests | 119,832,821,760.00 |
![]() | BioPharma Credit PLC - Net Income Including Non Controlling Interests | 101,856,345,600.00 |